The deadlines and procedures are set out in the evaluation result letter. For more information on complaints about proposal rejection: https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Complaints+about+proposal+rejection.

This is up to the experts to assess; all networks are highly encouraged to follow what is explained in FAQ n 16721.

One single IERO/IO (all branches included) cannot receive more than 40% of the total EC contribution. The country where the IERO is based won’t be counting towards the 40% rule, but it is the IERO itself which is counting (as if the IERO was considered as a separate country, but using the country correction coefficients of their hosts). Example: In a project, if there are European Molecular Biology Laboratory (EMBL) German and French branches, the budget requested by both branches will count towards the 40% rule for EMBL’s share, while this specific budget will not count for France’s or Germany’s share of the budget.

The university must be included (either as an associated partner or associated partner linked to a beneficiary) and they must provide a Letter of Commitment even if they only award the degree and have no other task.

No, it is not.

Yes, it is possible as long as it is well described in the proposal. It will be assessed accordingly by the experts during the evaluations. However, this set-up should not be used to circumvent some other rules, like the 40% rule.

All Open Science aspects are moved under Excellence in the methodology. Open Access should not be described under Impact and Dissemination as it is assessed under Excellence.

This requirement should be applicable to beneficiaries and not to associated partners.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.

This is mainly for statistics purposes.

The resubmission 70% rule applies as of 2021 proposals and re-submission in 2022. The conditions for MSCA-PF as stated on page 83-91 of the MSCA Work Programme 2021-2022 apply to both 2021 and 2022 calls, so it means that 2021 proposals cannot be resubmitted in 2022 and 2022 proposals cannot be resubmitted in 2023. Quoting page 85: “Proposals involving the same recruiting organisation (and for Global Postdoctoral Fellowships also the associated partner hosting the outgoing phase) and individual researcher submitted to the previous call of MSCA Postdoctoral Fellowships under Horizon Europe and having received a score of less than 70% must not be resubmitted the following year.” It means also that the researcher can (re)submit the proposal with a different host, so they are not totally banned from applying the following year.

In principle, yes, if for the 3 months the main activity would be in the other country, they would be eligible. However, if for example this is a secondment and their employment contract remains with the organisation in their home country, it probably does not classify as such and would rather be a ’short visit’ in the sense of the mobility rule.

Timesheets and declarations are not requested in MSCA projects (contrary to other Horizon Europe actions based on actual costs). To prove that the researcher worked on their MSCA project, it is sufficient to present a contract with the host institution together with additional documents proving the fellow’s dedication to the project, if needed.

Moreover, declarations are not allowed by the auditors. REA has confirmed that the declaration on exclusive work is not applicable for audits carried out in MSCA ITN, IF and COFUND actions to determine time spent working on the action. It is expected this will continue in Horizon Europe.

As outlined in the H2020 Indicative Audit Programme, such evidence may include lab books, attendance lists, conference abstracts, library records, travel expenses, timesheets, reports to supervisor, meeting minutes, e-mail exchanges, etc. and other open sources (e.g. the internet) to see if the researcher worked on activities other than their  project. The auditors will also look at the researcher’s employment contract or corresponding agreement to see if it complies with Article 32 of the H2020 Annotated Model Grant Agreement, including but not limited to the obligation that the researcher works exclusively for the action.

Fellows need documentation in the form of a contract that shows the 50% commitment or something similar since MSCA does not typically operate with timesheets.

Organisations can only encode secondments that are eligible for EC funding. So organisations could encode the secondments going to the UK, but not those from the UK to a beneficiary. It is the dates included in the mobility declarations (previously researchers’ declarations) which are used for financial reporting.  

The researcher is eligible to participate, the change of status does not affect their eligibility.

The UK partners will be funded with the UKRI Horizon Europe Guarantee, in line with the original budget line. They will no longer be able to be included as a beneficiary but will need to become Associated Partners (APs).  Secondments to UK APs from Member States (MS) and/ or Associated Countries (AC) will be funded by the EC as originally foreseen in the proposal. Secondments from UK APs to MS/ AC/ other APs will be funded via UKRI, in line with the budget line and secondment plan in the proposal. Secondments from another AP to the UK will also be funded via UKRI.